Supplement Claims Rules v. Drugs, Foods: FDA Opens Free Speech Debate
This article was originally published in The Tan Sheet
Executive Summary
FDA invites public comments on the constitutionality of its approach to regulating claims for dietary supplements compared with Rx drugs and foods in a notice appearing in the May 16 Federal Register
You may also be interested in...
Structure/Function Claim Pre-Market Substantiation Urged By Former FDAer
A mandatory pre-market substantiation program for structure/function claims covering both foods and dietary supplements should be created by FDA, former deputy commissioner for policy Michael Taylor contends
FDA OTC Labeling Guidance Allows Flexible Approach To Template Use
OTC drug manufacturers that choose to employ FDA's "Drug Facts" labeling templates do not have to follow them verbatim, the agency says in a guidance published in the Oct. 18 Federal Register
Supplement Promos To Health Professionals Merit More Flexibility – AHPA
Dietary supplement promotional speech targeted to health care practitioners should be allowed to contain substantiated disease treatment claims, the American Herbal Products Association maintains